Miriam Doepner
GlaxoSmithKline (United States)
ORCID: 0000-0002-9736-2651Also affiliated with University of Pennsylvania
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested β papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Papers
Driven by 7 papers. Top paper: βSomatic structural variation targets neurodevelopmental genes and identifies SHANK2 as a tumor suppressor in neuroblastomaβ.
Karina L. Conkrite, Miriam Doepner, Komal S. Rathi, Apexa Modi, Zalman Vaksman +13 more
Christopher A. Natale, In Young Lee, Swati Venkat, Sung Hoon Kim, John A. Katzenellenbogen +4 more
Jinyang Li, Shivahamy Maheswaran, Robert J. Norgard, Salina Yuan, Maimon E. Hubbi +12 more
Paola Kuri, Jonathan Zou, Adriana Blanco, Maxwell Marshall, Gabriella Rice +8 more
Miriam Doepner, Jillian Weissenrieder, Ariana D. Majer, Sophia Mercado, Angela Estell +6 more
Jinyang Li, Shivahamy Maheswaran, Robert J. Norgard, Salina Yuan, Maimon E. Hubbi +12 more
Miriam Doepner, Jillian Weissenrieder, Ariana D. Majer, Sophia Mercado, Angela Estell +6 more